E2F1 and colorectal adenocarcinoma: Monzo et al showed that transfection of anti-miR-17 resulted in increased E2F1 expression and decreased cell proliferation[35], and Kanaan et al showed that the transfection of miR-17 into HT-29 colorectal adenocarcinoma cells lead to decreased E2F1 expression[39].